Oxford, UK, 10 December 2015 – Karus Therapeutics (‘Karus’), a leader in the development of innovative medicines with breakthrough potential in the treatment of hematological cancers and solid tumor immunotherapy, today announced that it has entered into a strategic pre-clinical and clinical collaboration with The University of Texas MD Anderson Cancer Center. The collaboration will […]
Oxford, UK, 7 December 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that Simon Kerry, Karus Therapeutics’ CEO will be giving a company presentation at the 4thAnnual Cancer BioPartnering & Investment Forum, New York, USA on the 24th February 2016. For more information on […]
Design and Development of a Novel PI3K-p110ß/δ Inhibitor, KA2237 – Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity. Alexander A., Bone E.A., Cecil A.R.L., Colman L., Dow J., Finan P., Finnemore D., Gatland A., Haque K., Lensun L., Rogers H., Silva F.A., Ward P., Whale A., Shuttleworth S.J. 57th ASH Annual Meeting and Exposition, Orlando, […]
Design and Development of a Novel PI3K-p110ß/d Inhibitor, KA2237 – Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity. Alexander R., Bone E.A., Cecil A.R.L., Colman L., Dow J., Finan P., Finnemore D., Gatland A., Haque K., Lensun L., Rogers H., Silva F.A., Ward P., Whale A., Shuttleworth S.J. EORTC-NCI-EMA-AACR Conference on Innovation and Biomarkers in […]
Oxford, UK, 30th November 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that Simon Kerry, Karus Therapeutics’ CEO will be giving a company presentation at the Biotech Showcase, San Francisco, USA, 11th-13th January 2016. For more information on Karus’s presentations or for media enquiries, […]
Oxford, UK, 26th November 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving a poster presentation at the 57th ASH Annual Meeting, Orlando, USA. The poster presentation is entitled “Design and Development of a Novel Orally-Active, PI3K-p110Beta/Delta Inhibitor with Combined […]
Design and Development of a Novel PI3K-p110ß/δ Inhibitor, KA2237 – Combined Tumor Immunotherapeutic, Growth Inhibition and Anti-Metastatic Activity. Whale A.D., Alexander R., Bone E.A., Cecil A.R.L., Colman L., Dow J., Finan P., Finnemore D., Gatland A., Haque K., Lensun L., Rogers H., Silva F.A., Shuttleworth S.J. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, […]
Design and Development of a Novel HDAC6-Selective Inhibitor, KA2507, for Hematological Cancer Treatment and Solid Tumor Immunotherapy. Whale A.D., Alexander R., Bone E.A., Cecil A.R.L., Colman L., Dow J., Finan P., Finnemore D., Gatland A., Haque K., Lensun L., Rogers H., Silva F.A., Shuttleworth S.J. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, […]
Oxford, UK, 2 November 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving a poster presentation at the EORTC-NCI-EMA-AACR Innovation and Biomarkers in Cancer Drug Development, Brussels, Belgium. The conference will take place in 2016. The poster presentation is entitled […]
Oxford, UK, 4 October 2015 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of cancer, has announced that it will be giving two poster presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 5-9 November 2015, Boston, USA. The poster presentations are as follow: Abstract B115 […]
© Karus Therapeutics. All rights reserved
Registered in England & Wales No 05490954
VAT No 871 4126 33
Created by Instinctif Partners
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visit to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
The following cookies are also needed - You can choose if you want to allow them:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy